MAPK1 and cancer: To solve this question, we carried out this study with antibody microarray analysis, which revealed that highly increased MAPK1 was enriched in all of the upregulated pathways of RT-R-MDA-MB-231 cells (MAPK signaling, NOD-like receptor signaling, PI3K-Akt signaling, and Pathways in cancer).